Clinical Trial Update: A Study of SCTT11 in Healthy Participants and Participants with Thyroid Eye Disease. [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for SCTT11 in healthy participants and Thyroid Eye Disease patients, currently not yet recruiting (Phase 1 and Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• SCTT11

Snippet

Sponsor: Sinocelltech Ltd. | Conditions: TED | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING